Clinical Trial Update: Comparison of MMFS Dosages in Older Adults [Phase 2]

View source ↗

Summary

Phase 2 trial comparing MMFS dosages in older adults; completed study assessing anxiety, depression, sleep quality, and cognitive impairment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety
• Cognitive Impairment
• Major Depressive Disorder
• Sleep Disturbance

Drugs mentioned

• MMFS

Snippet

Sponsor: Neurocentria, Inc. | Conditions: Anxiety, Depression | Phase 2 | Status: COMPLETED